ALGN vs EBS · P/E 35, rev $4.00B vs rev $1.04B
Align Technology Inc (ALGN) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALGN revenue for 2024-12-31 was $4.00B. Net income was $421.4M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ALGN and EBS stock pages for the full models.
Not investment advice.